Iovance Biotherapeutics
Ulises Villavicencio has a diverse background with experience in quality assurance, auditing, research, and management. With a strong focus on compliance and regulations, Ulises has held various positions in the pharmaceutical industry, as well as in archaeology and nutraceuticals. From being a Lifeguard to a Quality Control Laboratory Manager, Ulises has showcased their ability to adapt and excel in different roles. Currently serving as Associate Director, QA Compliance at Iovance Biotherapeutics, Ulises continues to demonstrate their expertise in maintaining high levels of quality and compliance.
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.